Constipation, a common gastrointestinal disorder, often presents a diagnostic and therapeutic challenge. This article aims to elucidate a comprehensive approach to its diagnosis and treatment, enabling physicians to effectively manage this condition.
Diagnosis primarily relies on patients' symptoms, with Rome IV criteria being the standard. However, it's crucial to consider differential diagnoses, including irritable bowel syndrome and opioid-induced constipation. A thorough medical history, physical examination, and, if necessary, additional diagnostic tests such as colonoscopy or transit studies can help rule out secondary causes.
First-line treatment typically involves lifestyle modifications and over-the-counter remedies. Dietary changes, such as increasing fiber and fluid intake, can significantly improve symptoms. Osmotic laxatives are often effective, while stimulant laxatives are reserved for short-term use.
For patients unresponsive to first-line treatment, second-line options include prescription drugs such as lubiprostone, linaclotide, and plecanatide. These agents work by increasing intestinal fluid secretion and accelerating transit, thereby alleviating constipation. However, they may cause side effects like diarrhea and abdominal pain.
In refractory cases, biofeedback therapy or surgical intervention may be considered. Biofeedback is particularly beneficial for patients with dyssynergic defecation. Surgery, while rarely used, is an option for severe cases of slow-transit constipation or rectal prolapse.
Understanding constipation's complexity and adopting a comprehensive approach to its diagnosis and treatment is essential for effective patient management. By tailoring the approach to individual patient needs, physicians can significantly improve their patients' quality of life and reduce the burden of this common condition.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation